Compare CDNA & DXPE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CDNA | DXPE |
|---|---|---|
| Founded | 1998 | 1908 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 2.8B |
| IPO Year | 2007 | 1998 |
| Metric | CDNA | DXPE |
|---|---|---|
| Price | $84.86 | $171.98 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 2 |
| Target Price | $65.33 | ★ $200.00 |
| AVG Volume (30 Days) | ★ 1.3M | 138.3K |
| Earning Date | 10-29-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 27.25 |
| EPS | 2.45 | ★ 2.98 |
| Revenue | $48,324,000.00 | ★ $1,247,043,000.00 |
| Revenue This Year | $30.36 | $12.53 |
| Revenue Next Year | $6.23 | $8.07 |
| P/E Ratio | ★ $33.32 | $59.39 |
| Revenue Growth | ★ 18.93 | N/A |
| 52 Week Low | $14.27 | $84.04 |
| 52 Week High | $73.43 | $208.00 |
| Indicator | CDNA | DXPE |
|---|---|---|
| Relative Strength Index (RSI) | 79.73 | 46.59 |
| Support Level | $17.30 | $143.19 |
| Resistance Level | N/A | $175.09 |
| Average True Range (ATR) | 4.65 | 7.49 |
| MACD | 0.83 | 0.06 |
| Stochastic Oscillator | 80.27 | 54.16 |
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
DXP Enterprises Inc is engaged in the business of distributing maintenance, repair and operating (MRO) products, equipment and service to customers in various end markets, including general industrial, energy, food & beverage, chemical, transportation, water and wastewater. The company operates through three business segments: Service Centers, Innovative Pumping Solutions and Supply Chain Services. The majority of revenue is derived from the Service Centers segment, which provides a wide range of MRO products in the rotating equipment, bearing, power transmission, hose, fluid power, metal working, fastener, industrial supply, safety products and safety services categories. Geographically, it generates the maximum revenue from the United States.